The trademark AVENIO EDGE was filed by Roche Diagnostics GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 2, 2020, and received one opposition filed on March 25, 2020 by SAS Di'X on Likelihood of confusion. the opponent was represented by A2 ESTUDIO LEGAL and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued March 25, 2020
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on March 26, 2020. Change of name and address of the trademark registration was recorded on June 7, 2020.
Goods And Services
The mark was filed in class 1 with following description of goods:
Assays and reagents for scientific or medical research use
Labeling reagents for scientific or research purposes
Reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes
Reagents featuring magnetic beads for scientific or research purposes
Antibody reagents for scientific or research purposes
Buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes
Reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes
Reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes
Diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes
Reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing DNA, genotyping, gene expression profiling and high through-put screening
Reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research
Nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes
Reagents and chemical test kits for scientific and research use in connection with DNA sequencing and genetic analysis
In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science and research
Reagents for cell separation for scientific or research purposes.
The mark was filed in class 9 with following description of goods:
Automated laboratory apparatus and systems, namely, sample handlers and bar code readers, and software for use therewith sold as a unit
Namely, arrays, beads, bead sets and flow cells
Laboratory equipment, namely, devices for analysis of nucleic acids and for DNA sequencing.